Skip to content
Sign up to receive our free weekday morning edition, and you'll never miss a scoop.
The increasingly bitter fight between Anthropic and the Pentagon is forcing Congress to confront AI regulation for the armed forces.

Tech: Congress confronts AI warfare

The increasingly bitter fight between Anthropic and the Pentagon is forcing Congress to confront AI regulation for the armed forces.

We reported last week that members of both parties in the Senate Armed Services Committee are eager to use the National Defense Authorization Act to try to clarify how far contractors like the Claude-maker can go in putting limits on the government’s use of their tech.

Subscripion logo

You're seeing a preview of our Premium+ Tech coverage. Read the full story by subscribing here.

Tech Policy Tech

Presented by AstraZeneca

The 340B program was created to help patients. Instead, it’s helping hospitals earn massive profits. The 340B Rebate Model Pilot uses rapid verification of existing data to prevent duplicate discounts, strengthening program transparency and efficiency. Urge HHS to implement the Rebate Model Pilot and ensure 340B functions as intended. Get the facts.

Editorial photos provided by Getty Images. Political ads courtesy of AdImpact.

Presented by AstraZeneca

The 340B program is supposed to help vulnerable patients—but without strong safeguards, it’s siphoning away funds that could be used for free and charitable medicine. The 340B Rebate Model Pilot improves program integrity, preventing duplicate discounts and strengthening accountability. Urge HHS to implement the pilot today. Learn why it matters.

Welcome to Punchbowl News AM! We're glad to have you here.

Want to get more of what you need? Share a bit more about yourself to help us tailor your reader experience.

Thank you for signing up!

Thank you for signing up!

 

We have sent you a confirmation email. Please follow the provided instructions to complete your sign-up.

Thank you for confirming! You are now subscribed to the Punchbowl News AM list.

You're subscribed! Welcome to the community.